• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA082901J
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Perforation of Vessels (2135)
Event Date 11/16/2021
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore:on (b)(6) 2021, the patient underwent an endovascular treatment for an aortic arch aneurysm creating 2 debranch bypass and using the chimney technique for the brachiocephalic artery.In the procedure a gore® viabahn® vbx balloon expandable endoprosthesis (vbx device) was used.During the procedure, a vbx device (8x29) was implanted.After implantation, it was found that the vessel at the distal end of the vbx device (about 15 mm proximally from the right axillary anastomosis) was perforated, causing hypotension, and the patient went into shock.Manual hemostasis was performed and a blood transfusion (volume unknown) was required.An additional vbx device (8x59) was implanted at the injured site.The procedure was completed after confirming that the patient's condition had stabilized.
 
Manufacturer Narrative
A review of the manufacturing records indicated the device lots met all pre-release specifications.A direct device evaluation could not be performed as the device remains implanted.Communication revealed that the diameter of the blood vessel was not measured by ct prior to selection and use of the vbx device.Gore requested additional information on procedural details from the physician, but no additional information was provided.The gore® viabahn® vbx balloon expandable endoprosthesis instructions for use (ifu), for the appropriate region and time-period, was reviewed with respect to the complaint detail and there is an applicable precaution: ¿native vessel dimensions must be accurately measured, not estimated.¿ related statements are in the ifu under directions for use, imaging & measurement: ¿to achieve accurate measurement and ensure precise sizing and placement of the endoprosthesis, use image-centered, magnified-view contrast angiography, including a marker guidewire or catheter.¿ in addition, in directions for use, sizing and selection of the gore® viabahn® vbx balloon expandable endoprosthesis: ¿in selecting the appropriate size endoprosthesis, a careful assessment of the vessel is necessary.To reduce the potential for vessel damage, the final stent inner diameter (as indicated on the compliance chart on box label, the compliance chart is different per device size and it has more detailed information than table 2, stent graft sizing table) should approximate the diameter of the vessel just proximal and distal to the stenosis.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kaitlin barnash
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12918040
MDR Text Key284626862
Report Number2017233-2021-02580
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/10/2024
Device Catalogue NumberBXA082901J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/16/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/11/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention; Hospitalization;
Patient Age84 YR
Patient SexMale
-
-